Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens

International Journal of General Medicine

Volumn 6, Issue , 2013, Pages 383-386

  Ogrendik, Mesut ^a  

^a Nazilli State Hospital   (Turkey)

Author keywords

Animal models; Antibiotics; Chronic arthritis; Etiopathogenesis; Periodontitis; Porphyromonas gingivalis; Systemic disease

Indexed keywords

C REACTIVE PROTEIN; CHLOROQUINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DNA ANTIBODY; HLA DRB1 ANTIGEN; LEFLUNOMIDE; METHOTREXATE; PROTEIN ARGININE DEIMINASE; SALAZOSULFAPYRIDINE;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; DISEASE ASSOCIATION; DNA DNA HYBRIDIZATION; DNA ISOLATION; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HLA DRB1 GENE; HUMAN; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TANNERELLA FORSYTHENSIS;

EID: 84878584042     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S45929     Document Type: Article

References (25)

1. Bax M, van Heemst J, Huizinga TW, Toes RE. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics. 2011;63(8): 459-466.
2. Modi DK, Chopra VS, Bhau U. Rheumatoid arthritis and periodontitis: biological links and the emergence of dual purpose therapies. Indian J Dent Res. 2009;20(1):86-90.
3. Ogrendik M. Rheumatoid arthritis is linked to oral bacteria: etiological association. Mod Rheumatol. 2009;19(5):453-456.
4. Svartz N. The treatment of rheumatic polyarthritis with acid azo compounds. Rheumatism. 1948;4(1):180-185.
5. Das KM. Sulfasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Am. 1989;18(1):1-20.
6. Nakao R, Takigawa S, Sugano N, et al. Impact of minocycline ointment for periodontal treatment of oral bacteria. Jpn J Infect Dis. 2011;64(2): 156-160.
7. Tilley BC, Alarcón GS, Heyse SP, et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995;122(2):81-89.
8. Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis. Curr Med Res Opin. 2007;23:515-522.
9. Ogrendik M. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Clin Ther. 2009;31(8):1754-1764.
10. Ogrendik M, Karagoz N. Treatment of rheumatoid arthritis with roxithromycin: a randomized trial. Postgrad Med. 2011;123(5): 220-227.
11. Ogrendik M. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. South Med J. 2007;100(2):135-139.
12. Marsh PD, Martin MV. Oral Microbiology, 4th ed.Bodmin: MPG Books Ltd; 2001.
13. Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S. Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed. 2005;7(2):2.
14. Kinloch A, Tatzer V, Wait R, et al. Identification of citrullinated alphaenolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther. 2005;7(6):R1421-R1429.
15. Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62(9):2662-2672.
16. Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol. 2010;37(6):1105-1112.
17. Okada M, Kobayashi T, Ito S, et al. Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults. J Periodontol. 2011;82(10):1433-1441.
18. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol. 2006;24(6):656-663.
19. Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, Rizo-Rodríguez JC, Little JW, Loyola-Rodríguez JP. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol. 2009;36(12): 1004-1010.
20. Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J Clin Periodontol. 2005;32(7):708-713.
21. Bartold PM, Marino V, Cantley M, Haynes DR. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol. 2010;37(5):405-411.
22. Cantley MD, Haynes DR, Marino V, Bartold PM. Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. J Clin Periodontol. 2011;38(6):532-541.
23. Kinloch AJ, Alzabin S, Brintnell W, et al. Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4-IE-transgenic mice. Arthritis Rheum. 2011;63(12):3818-3823.
24. Mahdi H, Fisher BA, Källberg H, et al. Specific interaction between genotype, smoking, and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet. 2009;41(12): 1319-1324.
25. Finegold SM. Anaerobic Gram-negative bacilli. In:Baron S, editor. Medical Microbiology, 4th ed. Galveston, TX, USA: University of Texas Medical Branch at Galveston; 1996;chapter 20.